Physician
Olivera, Emma
Olivera, Emma was paid $1.34M by Medicaid between Jan 2018 and Dec 2024, across 50 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 31% of everything it billed.
33Billing provider infoOLIVERA, EMMA
DOWNERS GROVE, IL 60515
DOWNERS GROVE, IL 60515
33aNPI1902242076assigned 05/16/2013
33bProvider typePediatrics Physician
28Total paid$1.34M
24GClaims39,290
24DCodes billed50
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Illinois
Rank by total paid#93 of 1,805
Median peer was paid$55K
This provider vs. median24×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,895 | $242K | |
| 2019 | 11,406 | $365K | |
| 2020 | 9,534 | $316K | |
| 2021 | 6,445 | $220K | |
| 2022 | 461 | $17K | |
| 2023 | 1,291 | $56K | |
| 2024incomplete | 3,258 | $126K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 31% | 8,945 | 7,623 | $415K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 15% | 2,702 | 2,177 | $203K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 12% | 2,456 | 2,168 | $165K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 8.7% | 1,582 | 1,461 | $117K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 6.5% | 1,092 | 997 | $87K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.6% | 1,052 | 916 | $75K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 3.7% | 3,077 | 2,664 | $50K |
| 90670 | 2.3% | 1,694 | 1,398 | $30K | |
| 83655 | 1.3% | 1,527 | 1,259 | $18K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.2% | 639 | 463 | $16K |
| 90677 | 1.1% | 293 | 271 | $15K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.0% | 884 | 800 | $14K |
38 more codes
| 90686 | <1% | 1,470 | $13K | |
| 87428 | <1% | 200 | $13K | |
| 90651 | <1% | 469 | $12K | |
| 90698 | <1% | 1,224 | $10K | |
| 90633 | <1% | 1,046 | $8K | |
| 90734 | <1% | 367 | $7K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 534 | $7K |
| 90744 | <1% | 805 | $5K | |
| 90700 | <1% | 732 | $5K | |
| 90716 | <1% | 341 | $5K | |
| 90723 | <1% | 260 | $4K | |
| 90680 | <1% | 259 | $4K | |
| 90647 | <1% | 255 | $4K | |
| 85018 | <1% | 1,704 | $4K | |
| 90681 | <1% | 461 | $4K | |
| 90707 | <1% | 343 | $4K | |
| 90710 | <1% | 269 | $3K | |
| 90620 | <1% | 113 | $3K | |
| 90656 | <1% | 136 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 100 | $2K |
| 96127 | <1% | 148 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 145 | $2K |
| 99381 | <1% | 22 | $2K | |
| 90713 | <1% | 264 | $2K | |
| 90715 | <1% | 156 | $1K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 36 | $1K |
| 1220F | <1% | 854 | $997.50 | |
| 90648 | <1% | 129 | $864.88 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 17 | $703.46 |
| 0071A | <1% | 14 | $562.82 | |
| 87807 | <1% | 54 | $533.18 | |
| 90685 | <1% | 55 | $462.44 | |
| 90696 | <1% | 16 | $197.40 | |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 96 | $192.76 |
| 81002 | <1% | 58 | $150.80 | |
| G8539 | Functional outcome assessment documented as positive using a standardized tool and a care plan based on identified deficiencies is documented within two days of the functional outcome assessment | <1% | 65 | $76.84 |
| 86580 | <1% | 20 | $72.00 | |
| 2015F | 0% | 110 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.